 OUTLINE: This is a randomized, multicenter study. Patients are stratified according to weight loss within the past 6 months less than 5 vs at least 5, disease stage IIIB vs IV, and brain metastases present vs absent. Patients are randomized to 1 of 3 treatment arms. 